Celestial Labs ends with 11% premium

It was a good day for Celestial Labs, a Hyderabad based company in the bio-informatics and bio-technology sector, which maintained positive momentum through the day despite weak sentiment in the market.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney SME Special
moneycontrol.com

Home » News » IPO » IPO - New Listings

Jul 17, 2007, 09.19 PM | Source: Moneycontrol.com

Celestial Labs ends with 11% premium

It was a good day for Celestial Labs, a Hyderabad based company in the bio-informatics and bio-technology sector, which maintained positive momentum through the day despite weak sentiment in the market.

Like this story, share it with millions of investors on M3

Celestial Labs ends with 11% premium

It was a good day for Celestial Labs, a Hyderabad based company in the bio-informatics and bio-technology sector, which maintained positive momentum through the day despite weak sentiment in the market.

Post Your Comments

Share Cancel

It was a good day for Celestial Labs , a Hyderabad based company in the bio-informatics and bio-technology sector, which maintained positive momentum through the day despite weak sentiment in the market.

It has started the day at Rs 75, with premium of 25% over its issue price of Rs 60 and touched a high of Rs 104.90 with whopping gain of 75%.

The share closed at Rs 66.65, up 11.08%, with volumes of 1,04,37,211 shares on the NSE and at Rs 67.20, with volumes of 77,87,026 shares on the BSE.

The turnover for the day was at Rs 74.10 crore on the NSE.

In an interview with CNBC-TV18, Aditya Narayan Singh, CEO of Celestial Labs said that he expects the FY08 topline to be Rs 25 crore and net profits to be Rs 10 crore. He expects to maintain margins at 40%.

The company offers enterprise resources, planning solutions, database warehousing and bio services like clinical data management, molecular modelling and design and development of drug molecules.

The company had raised Rs 30 crore from its initial public offering (IPO) of 50-lakh equity shares of Rs 10 each at a price of Rs 60 per share.

The company plans to use the issue proceeds for enhancing existing infrastructure for bio informatics, for setting up of infrastructure for manufacturing of enzymes and for related activities.

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Celestial Labs ends with 11% premium

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login